LifeTech Scientific Corporation (HKG:1302)

Market Cap	7.83B +24.3%
Revenue (ttm)	1.45B +3.7%
Net Income	78.79M -71.1%
EPS	0.02 -70.3%
Shares Out	4.63B
PE Ratio	93.11
Forward PE	16.60
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,304,000
Average Volume	21,110,700
Open	1.710
Previous Close	1.690
Day's Range	1.680 - 1.720
52-Week Range	1.260 - 2.440
Beta	0.38
RSI	49.72
Earnings Date	Mar 30, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,276
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2024, LifeTech Scientific's revenue was 1.30 billion, an increase of 2.88% compared to the previous year's 1.27 billion. Earnings were 222.39 million, a decrease of -15.52%.

Financial numbers in CNY